関連する実験動画
Updated: Sep 9, 2025
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
346
[妊娠を希望する体重過多または肥満の女性の健康リスクと治療方法]
Clara Søndersted1, Emilie Bahne1, Rikke T Klemmensen1,2
1Afdeling for Klinisk og Translationel Forskning, Københavns Universitetshospital - Steno Diabetes Center Copenhagen.
Ugeskrift for laeger
|September 5, 2025
まとめ
肥満は生育能力と妊娠に 影響を及ぼします 妊娠中のライフスタイルの変更は肥満の女性に限られた成功を示しているため,妊娠前の介入が必要である.
科学分野:
- 生殖内分泌学
- 妊婦と胎児の医療
- 減量医学
背景:
- 生殖年齢の女性の肥満は,生殖能力と不良な妊娠結果に重大なリスクをもたらします.
- 妊娠中の肥満女性に対する現在のライフスタイルの介入は,限られた有効性を示しています.
- 妊産婦の肥満に伴うリスクを軽減するために,証拠に基づいた妊娠前の戦略が不可欠です.
研究 の 目的:
- 肥満の管理に関する現在の証拠を見直す
- 妊娠前と妊娠中の介入の有効性を評価する.
- この集団における減量外科手術と薬剤療法に関するガイドラインを提供すること.
主な方法:
- 肥満,生育力,妊娠,および胎児期の結果に焦点を当てた研究の包括的な文献レビュー.
- ライフスタイルの介入,減量手術,薬物療法 (例えばGLP-1アゴニスト) に関するデータの分析.
- 妊娠中における介入のリスクと利益の評価
主要な成果:
- 妊娠中のライフスタイルの介入は 肥満の女性の結果に最小限の影響を及ぼします
- 胎児の成長に対する母親のリスクのバランスをとって,慎重に選択された個体に対して,腹腔外科手術を考慮してもよい.
- グルカゴン類ペプチド-1 (GLP-1) ベースの治療は,未知の胎児間効果のために,妊娠前に中止する必要があります.
結論:
- 妊娠を計画している肥満の女性では 妊娠前の介入が最適です
- バリアトリック手術は 専門医による 細心の注意を払った 個別的な治療を必要とします
- 妊娠中にGLP-1治療は禁忌であり,妊娠前にかなりの洗浄期間が必要です.
関連する概念動画
01:26Stress Prevention and Stress Management Techniques IV
62
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
62
01:24Obesity
609
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
609
01:22Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
01:20Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
01:24Disorders of the Female Reproductive System
486
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
486
01:15Diabetes: Management and Pharmacotherapy
354
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354